top of page
Literature
Search
SPR to Examine Cross-Reactivity of Antibodies with Native and Variant SARS-CoV-2 Spike Proteins
Read about how Affinité's P4SPR™ advances COVID-19 research in terms of cross-reactivity of antibodies against spike protein variants.
Jul 30, 2021
bottom of page